Catheter Precision Inc. (NYSE MKT:VTAK) — Market Cap & Net Worth
Market Cap & Net Worth: Catheter Precision Inc. (VTAK)
Catheter Precision Inc. (NYSE MKT:VTAK) has a market capitalization of $2.24 Million ($2.24 Million) as of May 26, 2026. Listed on the NYSE MKT stock exchange, this USA-based company holds position #29767 globally and #5913 in its home market, demonstrating a 10.13% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Catheter Precision Inc.'s stock price $0.85 by its total outstanding shares 2692473 (2.69 Million). Analyse cash flow conversion of Catheter Precision Inc. to see how efficiently the company converts income to cash.
Catheter Precision Inc. Market Cap History: 2018 to 2026
Catheter Precision Inc.'s market capitalization history from 2018 to 2026. Data shows change from $267.56 Billion to $2.29 Million (-80.70% CAGR).
Catheter Precision Inc. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Catheter Precision Inc.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
6.02x
Catheter Precision Inc.'s market cap is 6.02 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2018 | $267.56 Billion | $6.26 Million | -$30.83 Million | 42762.43x | N/A |
| 2019 | $38.03 Billion | $7.20 Million | -$56.96 Million | 5282.84x | N/A |
| 2020 | $10.00 Billion | $4.41 Million | -$36.05 Million | 2270.72x | N/A |
| 2021 | $2.10 Billion | $22.00K | -$25.07 Million | 95460.41x | N/A |
| 2022 | $158.59 Million | $14.00K | -$26.86 Million | 11327.62x | N/A |
| 2023 | $10.77 Million | $442.00K | -$70.57 Million | 24.37x | N/A |
| 2024 | $1.21 Million | $420.00K | -$16.64 Million | 2.89x | N/A |
| 2025 | $4.93 Million | $819.00K | -$17.18 Million | 6.02x | N/A |
Competitor Companies of VTAK by Market Capitalization
Companies near Catheter Precision Inc. in the global market cap rankings as of May 26, 2026.
Key companies related to Catheter Precision Inc. by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #152 globally with a market cap of $151.99 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #196 globally with a market cap of $121.11 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #235 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
- Medtronic PLC (NYSE:MDT): Ranked #259 globally with a market cap of $97.77 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #152 | Abbott Laboratories | NYSE:ABT | $151.99 Billion | $87.41 |
| #196 | Stryker Corporation | NYSE:SYK | $121.11 Billion | $316.48 |
| #235 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
| #259 | Medtronic PLC | NYSE:MDT | $97.77 Billion | $78.60 |
Catheter Precision Inc. Historical Marketcap From 2018 to 2026
Between 2018 and today, Catheter Precision Inc.'s market cap moved from $267.56 Billion to $ 2.29 Million, with a yearly change of -80.70%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $2.29 Million | -53.55% |
| 2025 | $4.93 Million | +305.76% |
| 2024 | $1.21 Million | -88.72% |
| 2023 | $10.77 Million | -93.21% |
| 2022 | $158.59 Million | -92.45% |
| 2021 | $2.10 Billion | -79.00% |
| 2020 | $10.00 Billion | -73.70% |
| 2019 | $38.03 Billion | -85.79% |
| 2018 | $267.56 Billion | -- |
End of Day Market Cap According to Different Sources
On May 25th, 2026 the market cap of Catheter Precision Inc. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $2.24 Million USD |
| MoneyControl | $2.24 Million USD |
| MarketWatch | $2.24 Million USD |
| marketcap.company | $2.24 Million USD |
| Reuters | $2.24 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Catheter Precision Inc.
Catheter Precision, Inc. designs, manufactures, and sells medical technologies for the field of cardiac electrophysiology (EP) in the United States and Europe. The company's lead product is View into Ventricular Onset System, a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally … Read more